| RS1064795519 |
CHD7
|
Health Risk |
Likely pathogenic |
— |
| RS1064795521 |
MPZ
|
Health Risk |
Likely pathogenic |
— |
| RS1064795522 |
HGSNAT
|
Health Risk |
Conflicting classifications of pathogenicity |
Mucopolysaccharidosis, MPS-III-C |
| RS1064795525 |
BRCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary breast ovarian cancer syndrome |
| RS1064795530 |
SATB2
|
Health Risk |
Pathogenic |
Chromosome 2q32-q33 deletion syndrome, Chromosome 2q32-q33 deletion syndrome |
| RS1064795531 |
CACNA1A
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 42 |
| RS1064795533 |
CHRNA4
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal dominant nocturnal frontal lobe epilepsy, Autosomal dominant nocturnal frontal lobe epilepsy |
| RS1064795534 |
KIF1A
|
Health Risk |
Pathogenic/Likely pathogenic |
Neuropathy, hereditary sensory |
| RS1064795536 |
TRPV4
|
Health Risk |
Conflicting classifications of pathogenicity |
TRPV4-related disorder, Charcot-Marie-Tooth disease axonal type 2C |
| RS1064795538 |
DNM1
|
Health Risk |
Likely pathogenic |
— |
| RS1064795540 |
GJB1
|
Health Risk |
Pathogenic/Likely pathogenic |
Charcot-Marie-Tooth disease, Charcot-Marie-Tooth Neuropathy X |
| RS1064795543 |
TBL1XR1
|
Health Risk |
Pathogenic |
— |
| RS1064795546 |
HSPG2
|
Health Risk |
Likely pathogenic |
— |
| RS1064795547 |
TAB2
|
Health Risk |
Pathogenic |
— |
| RS1064795548 |
GYG1
|
Health Risk |
Likely pathogenic |
— |
| RS1064795549 |
DLD
|
Health Risk |
Conflicting classifications of pathogenicity |
Pyruvate dehydrogenase E3 deficiency, Pyruvate dehydrogenase E3 deficiency |
| RS1064795550 |
ATM
|
Health Risk |
Pathogenic/Likely pathogenic |
Ataxia-telangiectasia syndrome, Familial cancer of breast |
| RS1064795551 |
CDKN2A
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial melanoma, Hereditary cancer-predisposing syndrome |
| RS1064795554 |
ATM
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Ataxia-telangiectasia syndrome |
| RS1064795556 |
ATM
|
Health Risk |
Likely pathogenic |
— |
| RS1064795558 |
COL6A3
|
Health Risk |
Conflicting classifications of pathogenicity |
Bethlem myopathy 1A, Bethlem myopathy 1A |
| RS1064795559 |
MORC2
|
Health Risk |
Pathogenic/Likely pathogenic |
Charcot-Marie-Tooth disease axonal type 2Z, MORC2-related developmental disorder |
| RS1064795562 |
ERCC6
|
Health Risk |
Likely pathogenic |
— |
| RS1064795563 |
DYRK1A
|
Health Risk |
Pathogenic |
— |
| RS1064795567 |
PURA
|
Health Risk |
Likely pathogenic |
PURA-related severe neonatal hypotonia-seizures-encephalopathy syndrome, PURA-related severe neonatal hypotonia-seizures-encephalopathy syndrome |
| RS1064795570 |
KIF11
|
Health Risk |
Likely pathogenic |
— |
| RS1064795576 |
SCN2A
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 11 |
| RS1064795577 |
BRCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Breast-ovarian cancer, familial |
| RS1064795578 |
BRCA2
|
Health Risk |
Pathogenic |
Breast-ovarian cancer, familial |
| RS1064795579 |
SCN1A
|
Health Risk |
Pathogenic/Likely pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS1064795580 |
CHRNA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal dominant nocturnal frontal lobe epilepsy, Inborn genetic diseases |
| RS1064795581 |
KIRREL3
|
Health Risk |
Likely pathogenic |
— |
| RS1064795585 |
TBL1XR1
|
Health Risk |
Conflicting classifications of pathogenicity |
Pierpont syndrome, Pierpont syndrome |
| RS1064795586 |
MED13L
|
Health Risk |
Likely pathogenic |
— |
| RS1064795587 |
CTNS
|
Health Risk |
Likely pathogenic |
Nephropathic cystinosis, Nephropathic cystinosis |
| RS1064795588 |
NSD1
|
Health Risk |
Likely pathogenic |
Sotos syndrome, Sotos syndrome |
| RS1064795591 |
MSH6
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary nonpolyposis colorectal neoplasms |
| RS1064795593 |
BMPR1A
|
Health Risk |
Conflicting classifications of pathogenicity |
Juvenile polyposis syndrome, Hereditary cancer-predisposing syndrome |
| RS1064795596 |
MUTYH
|
Health Risk |
Pathogenic/Likely pathogenic |
Familial adenomatous polyposis 2, Hereditary cancer-predisposing syndrome |
| RS1064795597 |
FANCC
|
Health Risk |
Pathogenic/Likely pathogenic |
Fanconi anemia, Hereditary cancer-predisposing syndrome |
| RS1064795599 |
SLC52A2
|
Health Risk |
Likely pathogenic |
— |
| RS1064795600 |
BRCA1
|
Health Risk |
Pathogenic |
Breast-ovarian cancer, familial |
| RS1064795602 |
AKT3
|
Health Risk |
Likely pathogenic |
Megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome 2, Megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome 2 |
| RS1064795603 |
BRCA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary breast ovarian cancer syndrome, Hereditary cancer-predisposing syndrome |
| RS1064795606 |
EPG5
|
Health Risk |
Likely pathogenic |
Malignant tumor of urinary bladder, Malignant tumor of urinary bladder |
| RS1064795607 |
EP300
|
Health Risk |
Likely pathogenic |
— |
| RS1064795608 |
USP9X
|
Health Risk |
Likely pathogenic |
— |
| RS1064795610 |
ATP8A2
|
Health Risk |
Likely pathogenic |
— |
| RS1064795618 |
EEF1A2
|
Health Risk |
Conflicting classifications of pathogenicity |
Intellectual disability, autosomal dominant 38 |
| RS1064795620 |
SCN1A
|
Health Risk |
Likely pathogenic |
— |
| RS1064795621 |
PURA
|
Health Risk |
Likely pathogenic |
— |
| RS1064795622 |
MSH2
|
Health Risk |
Pathogenic |
Lynch syndrome 1, Hereditary nonpolyposis colorectal neoplasms |
| RS1064795623 |
ATM
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Ataxia-telangiectasia syndrome |
| RS1064795624 |
ATM
|
Health Risk |
Pathogenic |
Familial cancer of breast, Familial cancer of breast |
| RS1064795626 |
LARP7
|
Health Risk |
Likely pathogenic |
— |
| RS1064795628 |
CREBBP
|
Health Risk |
Likely pathogenic |
— |
| RS1064795629 |
MSH6
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary nonpolyposis colon cancer |
| RS1064795630 |
AGL
|
Health Risk |
Likely pathogenic |
— |
| RS1064795631 |
TH
|
Health Risk |
Likely pathogenic |
— |
| RS1064795632 |
TINF2
|
Health Risk |
Conflicting classifications of pathogenicity |
Dyskeratosis congenita, Dyskeratosis congenita |
| RS1064795634 |
NBN
|
Health Risk |
Pathogenic/Likely pathogenic |
Microcephaly, normal intelligence and immunodeficiency |
| RS1064795635 |
MEN1
|
Health Risk |
Likely pathogenic |
— |
| RS1064795636 |
ENG
|
Health Risk |
Pathogenic/Likely pathogenic |
Cardiovascular phenotype, Telangiectasia |
| RS1064795637 |
PTCH1
|
Health Risk |
Conflicting classifications of pathogenicity |
Gorlin syndrome, Hereditary cancer-predisposing syndrome |
| RS1064795638 |
BAP1
|
Health Risk |
Pathogenic |
BAP1-related tumor predisposition syndrome, Hereditary cancer-predisposing syndrome |
| RS1064795639 |
POLD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Colorectal cancer, susceptibility to |
| RS1064795640 |
PALB2
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary cancer-predisposing syndrome, Familial cancer of breast |
| RS1064795641 |
MSH2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary nonpolyposis colorectal neoplasms |
| RS1064795642 |
STK11
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Peutz-Jeghers syndrome |
| RS1064795645 |
SYNGAP1
|
Health Risk |
Likely pathogenic |
— |
| RS1064795647 |
GRIN2A
|
Health Risk |
Likely pathogenic |
Landau-Kleffner syndrome, Landau-Kleffner syndrome |
| RS1064795648 |
KAT6A
|
Health Risk |
Likely pathogenic |
— |
| RS1064795649 |
BRIP1
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary cancer-predisposing syndrome, Ovarian Cancers |
| RS1064795651 |
BRCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary breast ovarian cancer syndrome, Hereditary cancer-predisposing syndrome |
| RS1064795652 |
BRCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Breast-ovarian cancer, familial |
| RS1064795653 |
MSH2
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Lynch syndrome 1 |
| RS1064795654 |
BMPR1A
|
Health Risk |
Likely pathogenic |
— |
| RS1064795655 |
CHD8
|
Health Risk |
Likely pathogenic |
Intellectual developmental disorder with autism and macrocephaly, Autism spectrum disorder |
| RS1064795657 |
JAK3
|
Health Risk |
Likely pathogenic |
— |
| RS1064795660 |
FOXN1
|
Health Risk |
Likely pathogenic |
T-cell immunodeficiency, congenital alopecia |
| RS1064795661 |
SETD2
|
Health Risk |
Likely pathogenic |
— |
| RS1064795662 |
SLC6A1
|
Health Risk |
Likely pathogenic |
— |
| RS1064795664 |
AARS1
|
Health Risk |
Likely pathogenic |
Charcot-Marie-Tooth disease type 2, Charcot-Marie-Tooth disease type 2 |
| RS1064795665 |
SPTBN2
|
Health Risk |
Likely pathogenic |
— |
| RS1064795667 |
BAP1
|
Health Risk |
Likely pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1064795668 |
CACNA1G
|
Health Risk |
Likely pathogenic |
— |
| RS1064795672 |
CDKL5
|
Health Risk |
Pathogenic/Likely pathogenic |
Angelman syndrome-like, Developmental and epileptic encephalopathy |
| RS1064795675 |
ATM
|
Health Risk |
Pathogenic/Likely pathogenic |
Ataxia-telangiectasia syndrome, Ataxia-telangiectasia syndrome |
| RS1064795677 |
DYNC1H1
|
Health Risk |
Likely pathogenic |
— |
| RS1064795679 |
POLE
|
Health Risk |
Conflicting classifications of pathogenicity |
Colorectal cancer, susceptibility to |
| RS1064795680 |
ZC4H2
|
Health Risk |
Pathogenic |
— |
| RS1064795682 |
ARID1A
|
Health Risk |
Likely pathogenic |
— |
| RS1064795683 |
PQBP1
|
Health Risk |
Likely pathogenic |
— |
| RS1064795684 |
SLC20A2
|
Health Risk |
Likely pathogenic |
— |
| RS1064795685 |
COL6A2
|
Health Risk |
Likely pathogenic |
— |
| RS1064795686 |
DLG4
|
Health Risk |
Pathogenic |
Intellectual developmental disorder 62, Intellectual developmental disorder 62 |
| RS1064795687 |
CSPP1
|
Health Risk |
Likely pathogenic |
Joubert syndrome 21, Joubert syndrome 21 |
| RS1064795688 |
APC
|
Health Risk |
Pathogenic/Likely pathogenic |
Familial adenomatous polyposis 1, Hereditary cancer-predisposing syndrome |
| RS1064795689 |
ADAR
|
Health Risk |
Likely pathogenic |
— |
| RS1064795691 |
TP53
|
Health Risk |
Conflicting classifications of pathogenicity |
Li-Fraumeni syndrome, Li-Fraumeni syndrome 1 |